Owens & Minor cuts FY2022 guidance, announces executive reshuffle amid macro headwinds

ACCENDRA HEALTH INC/VA/

2022-Q3 EPS reported $1.05 revenue$7,404,368,000

Preliminary Q3 GAAP EPS $0.15-$0.17; adjusted EPS $0.39-$0.41.
FY2022 adjusted EPS guidance cut to $2.50-$2.60 (prev. $2.85-$3.15); adjusted EBITDA $527-$537M (prev. $570-$610M).
CFO Andy Long becomes EVP/CEO of Products & Healthcare Services segment; Alex Bruni promoted to EVP/CFO.
COO Jeff Jochims resigns; separation agreement provides 1.5x salary and bonus severance.
Weakness attributed to unfavorable macro, lower hospital volumes, and elevated customer stocking.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Alexander J. Bruni

Executive Vice President & Chief Financial Officer

ACH · ACCENDRA HEALTH INC/VA/

Effective: 2022-10-12
Filed: October 12, 2022, 7:59 PM ET

Alexander J. Bruni, age 46, has been appointed Executive Vice President & Chief Financial Officer of the Company replacing Mr. Long effective October 12, 2022.

Role change

Andrew G. Long

Executive Vice President, Chief Executive Officer of Products & Healthcare Services Segment

ACH · ACCENDRA HEALTH INC/VA/

Effective: 2022-10-12
Successor: Alexander J. Bruni
Filed: October 12, 2022, 7:59 PM ET

Andrew G. Long, the Company’s Executive Vice President & Chief Financial Officer has been appointed as Executive Vice President, Chief Executive Officer of the Company’s Products & Healthcare Services segment, effective October 12, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Alexander J. Bruni was appointed as Executive Vice President & Chief Financial Officer at ACCENDRA HEALTH INC/VA/.

Action: appointed
Role: Executive Vice President & Chief Financial Officer

Exact text from the filing

Alexander J. Bruni, age 46, has been appointed Executive Vice President & Chief Financial Officer of the Company replacing Mr. Long effective October 12, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Andrew G. Long was appointed as Executive Vice President, Chief Executive Officer of Products & Healthcare Services Segment at ACCENDRA HEALTH INC/VA/.

Action: appointed
Role: Executive Vice President, Chief Executive Officer of Products & Healthcare Services Segment

Exact text from the filing

Andrew G. Long, the Company’s Executive Vice President & Chief Financial Officer has been appointed as Executive Vice President, Chief Executive Officer of the Company’s Products & Healthcare Services segment, effective October 12, 2022.

View on SEC.gov

ACCENDRA HEALTH INC/VA/ filing history →

Source: SEC EDGAR

accession 0001193125-22-261008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.